Structure, function, and regulation of the Hsp90 machinery

MM Biebl, J Buchner - Cold Spring Harbor perspectives …, 2019 - cshperspectives.cshlp.org
Heat shock protein 90 (Hsp90) is a molecular chaperone involved in the maturation of a
plethora of substrates (“clients”), including protein kinases, transcription factors, and E3 …

Modulation of protein–protein interactions for the development of novel therapeutics

I Petta, S Lievens, C Libert, J Tavernier… - Molecular Therapy, 2016 - cell.com
Protein–protein interactions (PPIs) underlie most biological processes. An increasing
interest to investigate the unexplored potential of PPIs in drug discovery is driven by the …

Advances in the medical treatment of Cushing's syndrome

RA Feelders, J Newell-Price, R Pivonello… - The lancet Diabetes & …, 2019 - thelancet.com
Cushing's syndrome is associated with multisystem morbidity and, when suboptimally
treated, increased mortality. Medical therapy is an option for patients if surgery is not …

Identification of recurrent USP48 and BRAF mutations in Cushing's disease

J Chen, X Jian, S Deng, Z Ma, X Shou, Y Shen… - Nature …, 2018 - nature.com
Cushing's disease results from corticotroph adenomas of the pituitary that hypersecrete
adrenocorticotropin (ACTH), leading to excess glucocorticoid and hypercortisolism …

Anticancer inhibitors of Hsp90 function: beyond the usual suspects

G Garg, A Khandelwal, BSJ Blagg - Advances in cancer research, 2016 - Elsevier
The 90-kDa heat-shock protein (Hsp90) is a molecular chaperone responsible for the
stability and function of a wide variety of client proteins that are critical for cell growth and …

Cushing's disease

H Nishioka, S Yamada - Journal of clinical medicine, 2019 - mdpi.com
In patients with Cushing's disease (CD), prompt diagnosis and treatment are essential for
favorable long-term outcomes, although this remains a challenging task. The differential …

Genetic and epigenetic causes of pituitary adenomas

M Chang, C Yang, X Bao, R Wang - Frontiers in endocrinology, 2021 - frontiersin.org
Pituitary adenomas (PAs) can be classified as non-secreting adenomas, somatotroph
adenomas, corticotroph adenomas, lactotroph adenomas, and thyrotroph adenomas …

Molecular derangements and the diagnosis of ACTH-dependent Cushing's syndrome

LK Nieman - Endocrine Reviews, 2022 - academic.oup.com
Endogenous Cushing's syndrome (CS) is associated with morbidities (diabetes,
hypertension, clotting disorders) and shortens life because of infections, pulmonary …

Genetics of Cushing's disease

J Simon, M Theodoropoulou - Journal of Neuroendocrinology, 2022 - Wiley Online Library
Corticotroph tumours are primarily sporadic monoclonal neoplasms and only rarely found in
genetic syndromes. Recurrent mutations in the ubiquitin specific protease 8 (USP8) gene …

Medical management of Cushing's syndrome: current and emerging treatments

JM Hinojosa-Amaya, D Cuevas-Ramos, M Fleseriu - Drugs, 2019 - Springer
Endogenous Cushing's syndrome is a chronic disease associated with increased morbidity
and mortality if not appropriately treated. Recurrence and/or persistence of …